⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL316123 | 0.84 | — | — | |
| SCHEMBL22344982 | 0.78 | — | — | |
| SCHEMBL316640 | 0.73 | — | — | |
| SCHEMBL15555699 | 0.68 | PARP1 (0.30) | — | |
| SCHEMBL1949798 | 0.68 | — | — | |
| SCHEMBL1666899 | 0.65 | ALDH1A1 (0.34) | — | |
| SCHEMBL28736699 | 0.65 | — | — | |
| SCHEMBL12457457 | 0.65 | HASPIN (0.30) | — | |
| SCHEMBL4083093 | 0.64 | — | — | |
| SCHEMBL16503647 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025027051-A1 | SPHINGOSINE-1-PHOSPHATE LYASE INHIBITORS FOR USE IN THE TREAMENT OF NEURODEGENERATIVE DISEASES | AB SCIENCE (FR) | 2025-02-06 | — | — | WO | claimed |
| US-10624877-B2 | Composition and method for treatment of symptoms associated with various skin conditions | THERACEUTIX, LLC (US) | 2020-04-21 | — | — | US | claimed |
| US-20180133196-A1 | COMPOSITION AND METHOD FOR TREATMENT OF SYMPTOMS ASSOCIATED WITH VARIOUS SKIN CONDITIONS | THERACEUTIX, LLC | 2018-05-17 | — | — | US | claimed |
| US-9968590-B2 | Composition and method for treatment of symptoms associated with various skin conditions | THERACEUTIX, LLC (US) | 2018-05-15 | — | — | US | claimed |
| US-20140212362-A1 | COMPOSITION AND METHOD FOR TREATMENT OF SYMPTOMS ASSOCIATED WITH VARIOUS SKIN CONDITIONS | THERACEUTIX, LLC (US) | 2014-07-31 | — | — | US | claimed |
| WO-2013049272-A2 | COMPOSITION AND METHOD FOR TREATMENT OF SYMPTOMS ASSOCIATED WITH VARIOUS SKIN CONDITIONS | THERACEUTIX, LLC (US) | 2013-04-04 | — | — | WO | claimed |
| EP-2010501-A2 | IMIDAZOLE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE | Lexicon Pharmaceuticals, Inc. (US) | 2009-01-07 | — | — | EP | claimed |
| US-20080248032-A1 | Using 2-acetyl-4-tetrahydroxybutylimidazole (THI) as therapeutic in treatment and prevention of heart and stroke injury | CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) | 2008-10-09 | — | — | US | claimed |
| WO-2007100617-A2 | IMIDAZOLE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE | LEXICON PHARMACEUTICALS, INC. (US) | 2007-09-07 | — | — | WO | claimed |
| WO-2025027051-A1 | SPHINGOSINE-1-PHOSPHATE LYASE INHIBITORS FOR USE IN THE TREAMENT OF NEURODEGENERATIVE DISEASES | AB SCIENCE (FR) | 2025-02-06 | — | — | WO | disclosed |
| EP-4017844-B1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | AC BIOSCIENCE SA (CH) | 2024-01-24 | — | — | EP | disclosed |
| US-20220306587-A1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | AC BIOSCIENCE SA (CH) | 2022-09-29 | — | — | US | disclosed |
| EP-4017844-A1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | AC BioScience SA (CH) | 2022-06-29 | — | — | EP | disclosed |
| WO-2021032857-A1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | AC BIOSCIENCE SA (CH) | 2021-02-25 | — | — | WO | disclosed |
| EP-2010501-A2 | IMIDAZOLE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE | Lexicon Pharmaceuticals, Inc. (US) | 2009-01-07 | — | — | EP | disclosed |
| WO-2008124210-A1 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING INFECTION USING LEUKOCYTE SEQUESTRATION AGENTS | EMORY UNIVERSITY (US) | 2008-10-16 | — | — | WO | disclosed |
| US-20080248032-A1 | Using 2-acetyl-4-tetrahydroxybutylimidazole (THI) as therapeutic in treatment and prevention of heart and stroke injury | CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) | 2008-10-09 | — | — | US | disclosed |
| WO-2008109314-A1 | HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE | LEXICON PHARMACEUTICALS, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2007100617-A2 | IMIDAZOLE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE | LEXICON PHARMACEUTICALS, INC. (US) | 2007-09-07 | — | — | WO | disclosed |
| US-20070208063-A1 | Imidazole-based compounds, compositions comprising them and methods of their use | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2007-09-06 | — | — | US | disclosed |